Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

23,751 total articles

Getty Realty Corp. Announces Regular Quarterly Cash Dividend

Getty Realty Corp. Announces Regular Quarterly Cash Dividend

Getty Realty Corp., a net lease REIT specializing in convenience and automotive retail real estate, announced a cash dividend of $0.485 per common share payable July 9, 2026, to shareholders of record as of June 25, 2026. The company’s portfolio comprises 1,174 properties across 44 U.S. states and Washington, D.C.

Bank OZK Announces First Quarter 2026 Earnings

Bank OZK Announces First Quarter 2026 Earnings

Bank OZK announced its first quarter 2026 financial results, reporting net income available to common stockholders of $159.3 million, a 5.1% decrease year-over-year, and diluted earnings per share of $1.44, down 2.0%. The bank highlighted its strong management and strategic positioning to navigate ongoing macroeconomic and geopolitical challenges.

Interparfums, Inc. Reports 2026 First Quarter Net Sales

Interparfums, Inc. Reports 2026 First Quarter Net Sales

Interparfums, Inc. reported a 2% increase in consolidated net sales for Q1 2026 to $345 million, driven by solid performances in select brands and favorable foreign exchange rates. Organic sales declined by 2% when adjusted for the Middle East conflict. Key growth brands included Coach and Montblanc, while Lacoste and overall Jimmy Choo sales decli…

Immuneering to Present New Survival Data from First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP in an Oral Presentation at the 2026 ASCO Annual Meeting

Immuneering to Present New Survival Data from First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP in an Oral Presentation at the 2026 ASCO Annual Meeting

Immuneering announced it will present updated survival data from a Phase 2a clinical trial evaluating the combination of atebimetinib and modified gemcitabine/nab-paclitaxel (mGnP) in first-line pancreatic cancer patients. The expanded cohort includes 55 patients, highlighting the drug's mechanism designed to improve survival by durable tumor shrin…

American Coastal Insurance Corporation  Schedules First Quarter Financial Results and Conference Call

American Coastal Insurance Corporation Schedules First Quarter Financial Results and Conference Call

American Coastal Insurance Corporation, a Florida-based insurance holding company specializing in insuring condominium and homeowner association properties, plans to release its Q1 2026 financial results on May 5, 2026. The company will hold a conference call immediately after, providing remarks and a Q&A session to discuss the quarter's performanc…

Oculis Publishes Invitation to the Annual General Meeting

Oculis Publishes Invitation to the Annual General Meeting

Oculis Holding AG has published its invitation to the 2026 Annual General Meeting scheduled for May 13, 2026, in Zug, Switzerland, including details for in-person attendance and webcast access. Additionally, the company will host a shareholder information session on May 11, focusing on meeting proposals and company updates. Oculis continues to adva…

AvePoint to Announce First Quarter 2026 Financial Results on May 7

AvePoint to Announce First Quarter 2026 Financial Results on May 7

AvePoint, a leader in AI data protection and governance, announced it will report its Q1 2026 financial results on May 7, 2026, followed by a conference call to discuss financial performance and business trends. The company provides unified data security and resilience solutions across multiple cloud platforms, serving over 28,000 customers globall…

Foghorn Therapeutics Presents New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and for Selective CBP, EP300 and ARID1B Degrader Programs at the 2026 AACR Annual Meeting

Foghorn Therapeutics Presents New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and for Selective CBP, EP300 and ARID1B Degrader Programs at the 2026 AACR Annual Meeting

Foghorn Therapeutics presented new preclinical data demonstrating the efficacy and safety of its innovative drug candidates targeting chromatin regulatory proteins involved in cancer. The lead compound, selective SMARCA2 inhibitor FHD-909, in combination with an anti-PD-1 antibody, showed complete and durable tumor regression and immune memory in m…

Cytokinetics to Announce First Quarter Results on May 5, 2026

Cytokinetics to Announce First Quarter Results on May 5, 2026

Cytokinetics, a biopharmaceutical company specializing in cardiac muscle biology, announced its plan to release first quarter 2026 financial results on May 5, 2026, followed by a management conference call to discuss its financial performance and business updates. The company is advancing its pipeline of cardiac therapies, including the approved dr…

Belite Bio Initiates Rolling Submission of New Drug Application to the U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease

Belite Bio Initiates Rolling Submission of New Drug Application to the U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease

Belite Bio has initiated the rolling submission of a New Drug Application (NDA) to the FDA for tinlarebant, an oral therapy aimed at treating Stargardt disease type 1 (STGD1). The drug has received Breakthrough Therapy Designation and is backed by positive Phase 3 clinical data. The company plans to complete submission by Q2 2026 and is preparing f…

Quadrant Reaches New Heights With F1 Drivers Collaboration

Quadrant Reaches New Heights With F1 Drivers Collaboration

Sports Entertainment Gaming Global Corporation's subsidiary Quadrant has released a high-engagement YouTube video featuring Formula 1 drivers Carlos Sainz Jr. and Lando Norris, celebrating the 100th anniversary of karting. The campaign generated over four million views and significant social media impressions, reinforcing Quadrant's content strateg…

S&P upgrades SiriusPoint’s Insurance Subsidiaries to ‘A’ based on consistent robust earnings and strength of capital position

S&P upgrades SiriusPoint’s Insurance Subsidiaries to ‘A’ based on consistent robust earnings and strength of capital position

SiriusPoint Ltd has received an upgrade from S&P Global Ratings on its core insurance operating subsidiaries to 'A' from 'A-', marking the company's third upgrade this year. The holding company rating was also raised to 'BBB+' from 'BBB' with a stable outlook. The upgrades are attributed to SiriusPoint's consistent underwriting performance, de-risk…

Table for Mom: OpenTable Launches Mother’s Day Dining Trends and Canada’s Top 100 Brunch and Lunch Restaurants for 2026

Table for Mom: OpenTable Launches Mother’s Day Dining Trends and Canada’s Top 100 Brunch and Lunch Restaurants for 2026

OpenTable, part of Booking Holdings, Inc., announced its annual Top 100 Brunch and Lunch Restaurants in Canada for 2026 and shared consumer trends for Mother’s Day dining, revealing that 65% of Canadians consider dining out an important part of their celebration. The data highlights evolving celebration styles including solo dining, larger family g…